Previous Page  107 / 490 Next Page
Information
Show Menu
Previous Page 107 / 490 Next Page
Page Background

SUNDAY 1 MAY 2016

105

SCIENTIFIC PROGRAMME

| PROGRAMME AND EXHIBITION GUIDE

Symposium

RADIOTHERAPY OF PROSTATE CANCER: TECHNICAL CHALLENGES

14:15 - 15:30 | AUDITORIUM

This GU symposium is aimed at reviewing the most challenging technical innovations in the field of ra-

diation therapy for localized prostate cancer. The speakers will cover relevant aspects regarding 3 topics:

1) Dr Alberto Bossi will review the current status of focal therapy with special focus on indications, tech-

niques, results and limitations. 2) Dr Peter Hoskin will analyse the emergent role of HDR brachytherapy

in dose escalation RT, radiobiological basis and the updated results of randomised trial. 3) Finally, Dr

Widmark, will discuss the relevant aspects of extreme hypofractionation: indications and clinical trials.

Chair: A. Zapatero (Spain)

Co-chair: S. Arcangeli (Italy)

14:15 > Extreme hypofractionation: indications and results

Speaker: L. Beckman (Sweden)

SP-0299

14:40 > Focal strategies: ready for prime time?

Speaker: A. Bossi (France)

SP-0300

15:05 > Brachytherapy as a boost: the way to go?

Speaker: P. Hoskin (UK)

SP-0301

Debate

THIS HOUSE BELIEVES THAT SBRT SHOULD BECOME THE STANDARD

OF CARE FOR T1 AND SMALL T2 NSCLC TUMOURS

14:15 - 15:30 | GIALLA

Stereotactic body radiotherapy (SBRT) has become the standard of care for patients, who are medically

inoperable. This is because of high local control rates combined with a favorable toxicity profile, even

in high-risk and elderly populations. With overall survival after SBRT mostly influenced by the patients`

comorbidities, it is discussed controversially, whether SBRT might be an alternative to surgical resection.

The lack of high level of evidence, concerns regarding omission of regional treatment and the lack of

histopathology are points against this motion. Consistent evidence in non-randomised studies and in a

small pooled analysis of two randomised studies speak for the motion.

Chair: M. Guckenberger (Switzerland)

Chair: D. De Ruysscher (The Netherlands)

14:15 > For the motion

Speaker: K. Franks (UK)

SP-0302

14:35 > Against the motion

Speaker: P. Van Schil (Belgium)

SP-0303

14:55 > For the motion rebuttal

Speaker: K. Franks (UK)